首站-论文投稿智能助手
典型文献
MiR-516a-3p is a Novel Mediator of Hepatocellular Carcinoma Oncogenic Activity and Cellular Metabolism
文献摘要:
Hepatocellular carcinoma(HCC)remains one of the most lethal malignancies.We previously demon-strated that the chromosome 19 microRNA cluster(C19MC)was associated with tumor burden and prog-nosis in patients with HCC.In the current study,we aim to explore the role of miR-516a-3p-an identical mature microRNA(miRNA)co-spliced by four oncogenic pre-miRNAs of C19MC(i.e.,mir-516a-1,mir-516a-2,mir-516b-1,and mir-516b-2)—in HCC.In our cohort of HCC patients,miR-516a-3p was highly expressed in HCC tissues in comparison with adjacent non-tumor tissues.High expression of tumor miR-516a-3p significantly correlated with advanced tumor stages,distinguished high HCC recurrence and mortality,and independently predicted poor prognosis.We further found that miR-516a-3p enhanced the proliferation,migration,and invasiveness of HCC cells in vitro and promoted tumor growth and metastasis in vivo.Among cancer cells,miR-516a-3p could be delivered via exosomes or extracellular vesicles and increased the oncogenic activity of recipient cells.Moreover,we performed comprehensive transcriptomics,proteomics,and metabolomics analysis on the potential mechanism underlying miR-516a-3p-promoted oncogenicity.MixOmic DIABLO analysis showed a close correlation and strong cluster consistency between the proteomics and metabolomics datasets.We further confirmed six proteins(i.e.,LMBR1,CHST9,RBM3,SLC7A6,PTGFRN,and NOL12)as the direct targets of miR-516a-3p and as central players in miR-516a-3p-mediated metabolism regulation.The integrated multi-omics and co-enriched pathway analysis showed that miR-516a-3p regulates the metabolic pathways of HCC cells,particularly purine and pyrimidine metabolism.In conclusion,our findings suggest that miR-516a-3p promotes malignant behaviors in HCC cells by regulating cellular metabolism and affecting neighboring cells via the exosome delivery system.Thus,we suggest miR-516a-3p as a novel molecular target for HCC therapy.
文献关键词:
作者姓名:
Tao Rui;Xueyou Zhang;Shi Feng;Haitao Huang;Shaowei Zhan;Haiyang Xie;Lin Zhou;Shusen Zheng;Qi Ling
作者机构:
Department of Surgery,Affiliated Hangzhou First People's Hospital,Zhejiang University School of Medicine,Hangzhou 310003,China;Department of Surgery,Collaborative Innovation Center for the Diagnosis and Treatment of Infectious Diseases,the First Affiliated Hospital,Zhejiang University School of Medicine,Hangzhou 310003,China;Key Laboratory of Organ Transplantation,Research Center for Diagnosis and Treatment of Hepatobiliary Diseases,Zhejiang Province,Hangzhou 310003,China
文献出处:
引用格式:
[1]Tao Rui;Xueyou Zhang;Shi Feng;Haitao Huang;Shaowei Zhan;Haiyang Xie;Lin Zhou;Shusen Zheng;Qi Ling-.MiR-516a-3p is a Novel Mediator of Hepatocellular Carcinoma Oncogenic Activity and Cellular Metabolism)[J].工程(英文),2022(09):162-175
A类:
516a,Oncogenic,C19MC,516b,oncogenicity,MixOmic,LMBR1,CHST9,SLC7A6,PTGFRN,NOL12
B类:
MiR,3p,Novel,Mediator,Hepatocellular,Carcinoma,Activity,Cellular,Metabolism,carcinoma,HCC,remains,one,most,lethal,malignancies,We,previously,demon,strated,that,chromosome,microRNA,cluster,was,associated,tumor,burden,patients,In,current,study,aim,explore,role,identical,mature,spliced,by,four,miRNAs,mir,cohort,highly,expressed,tissues,comparison,adjacent,High,expression,significantly,correlated,advanced,stages,distinguished,recurrence,mortality,independently,predicted,poor,prognosis,further,found,enhanced,proliferation,migration,invasiveness,cells,vitro,promoted,growth,metastasis,vivo,Among,cancer,could,delivered,via,exosomes,extracellular,vesicles,increased,activity,recipient,Moreover,performed,comprehensive,transcriptomics,proteomics,metabolomics,analysis,potential,mechanism,underlying,DIABLO,showed,close,correlation,strong,consistency,between,datasets,confirmed,six,proteins,RBM3,direct,targets,central,players,mediated,metabolism,regulation,integrated,multi,enriched,regulates,metabolic,pathways,particularly,purine,pyrimidine,conclusion,findings,suggest,promotes,malignant,behaviors,regulating,affecting,neighboring,delivery,system,Thus,novel,molecular,therapy
AB值:
0.466925
相似文献
Overexpression of Protein Phosphatase 2 Regulatory Subunit B"Alpha Promotes Glycolysis by Regulating Hexokinase 1 in Hepatocellular Carcinoma
JIAO Ning;JI Wan Sheng;ZHANG Biao;SHANG Yu Kui;ZHANG Yu Chen;YU Wei Qun;JIN Hai Long;LI Chao;ZHANG Cheng Ying;YAN Cheng;YUE Wen;ZHANG Qing-Weifang Medical university,Weifang 261053,Shandong,China;Department of Organ Transplantation,The Third Medical Center of PLA General Hospital,Beijing 100039,China;Clinical Research Center,Affiliated Hospital of Weifang Medical University,Weifang 261042,Shandong,China;Stem Cell and Regenerative Medicine Lab,Institute of Health Service and Transfusion Medicine,Beijing 100850,China;Department of Basic Medical Sciences,School of Medicine,Tsinghua University,Beijing 100083,China;Senior Department of Ophthalmology,The Third Medical Center of PLA General Hospital,Beijing 100039,China;Department of General Practice,The Third Medical Center of PLA General Hospital,Beijing 100039,China
Microrna-1224-5p Is a Potential Prognostic and Therapeutic Biomarker in Glioblastoma:Integrating Bioinformatics and Clinical Analyses
Xing WEI;Qing-mei ZHANG;Chang LIU;Song WU;Wei-xia NONG;Ying-ying GE;Li-na LIN;Feng LI;Xiao-xun XIE;Bin LUO-Department of Histology and Embryology,School of Pre-clinical Medicine,Guangxi Medical University,Nanning 530021,China;Department of Neurology,the First Affiliated Hospital,Guangxi Medical University,Nanning 530021,China;Central Laboratory of Pre-Clinical Medicine(Key Laboratory of Guangxi Colleges and Universities),Guangxi Medical University,Nanning 530021,China;Department of Neurosurgery,the First Affiliated Hospital,Guangxi Medical University,Nanning 530021,China;Key Laboratory of Early Prevention and Treatment of Regional High Frequency Tumor(Guangxi Medical University),Ministry of Education,Nanning 530021,China
Overexpression of MiR-633 Suppresses the Tumorigenicity of Gastric Cancer Cells and Induces Apoptosis by Targeting MAPK1
Hai-long LI;Yao-hui SONG;Zheng-ping DU;Yong-hua HU;Zhuan-xiong WANG;Xi CHEN;Xing-mei LU;Ying-xia CHEN;Yong-qiang DUAN;Xiang-dong ZHU-Department of Geriatrics,Affiliated Hospital of Gansu University of Traditional Chinese Medicine,Lanzhou 730000,China;Department of Internal Medicine,The First Clinical Medical College,Gansu University of Chinese Medicine,Lanzhou 730000,China;Provincial-Level Key Laboratory for Molecular Medicine of Major Diseases and The Prevention and Treatment with Traditional Chinese Medicine in Gansu Colleges and Universities,Gansu University of Chinese Medicine,Lanzhou 730000,China;School of Basic Medicine,Gansu Vocational College of Health,Lanzhou 730300,China;College of Traditional Chinese Medicine,Ningxia Medical University,Yinchuan 750004,China
High Expression of Fibronectin 1 Predicts a Poor Prognosis in Glioblastoma
Song WU;Chang LIU;Xing WEI;Wei-xia NONG;Li-na LIN;Feng LI;Xiao-xun XIE;Xing-sheng LIAO;Bin LUO;Qing-mei ZHANG;Shao-wen XIAO-Department of Neurosurgery,the First Affiliated Hospital,Guangxi Medical University,Nanning 530021,China;Department of Histology and Embryology,School of Pre-clinical Medicine,Guangxi Medical University,Nanning 530021,China;Department of Neurology,the First Affiliated Hospital,Guangxi Medical University,Nanning 530021,China;Key Laboratory of Early Prevention and Treatment of Regional High Frequency Tumor(Guangxi Medical University),Ministry of Education,Nanning 530021,China;Central Laboratory of Pre-Clinical Medicine(Key Laboratory of Guangxi Colleges and Universities),Guangxi Medical University,Nanning 530021,China
机标中图分类号,由域田数据科技根据网络公开资料自动分析生成,仅供学习研究参考。